Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Merck & Co Inc
NYSE:MRK
$89.51

Financials

Curr Year EPS Estimate8.93
Next Quarter EPS Estimate2.42
Profit Margin25.87%
Operating Margin35.05
Return on Assets0.13
Return on Equity0.35
Revenue63.4B
Earnings Per Share6.49
Revenue Per Share25.21
Gross Profit49,245,999,104
Quarterly Revenue Growth-0.02

General

NameMerck & Co Inc
TickerMRK
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees73,000

About Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividend

Merck & Co Inc pays out a dividend of $3.22 per share, with a dividend yield of 3.60%.

MRK's next dividend payment will be made to shareholders on October 7, 2025.

They pay out 46.32% of their earnings out as a dividend.

Recent Dividends

Oct 7, 2025$0.81
Jul 8, 2025$0.81
Apr 7, 2025$0.81
Jan 8, 2025$0.81
Oct 7, 2024$0.77
Jul 8, 2024$0.77
Apr 5, 2024$0.77
Jan 8, 2024$0.77
Popular

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Ukraine expects $3.5 billion fund for US weapons to sustain fight against Russia, Zelenskyy says

KYIV, Ukraine (AP) — Ukraine expects there will be around $3.5 billion by next month in a fund to buy weapons from the United States and help sustain its against Russia’s all-out invasion, Ukrainian President Volodymyr Zelenskyy said Wednesday.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

US Attorney Erik Siebert Resigns After Refusing Trump Pressure To Pursue Criminal Case Against NY AG Letitia James: Report

U.S. Attorney Erik Siebert resigned after refusing Trump administration pressure to charge New York AG Letitia James without evidence, a move critics call political retribution.

Embed-Chart-H-1B-Visas-Explainer-Application Approvals, ADVISORY

H-1B-VISAS-EXPLAINER-APPLICATION APPROVALS — Chart. The following digital embed shows the number of approved H1-B applications by type since 2010. This chart is current as of Sept. 22, 2025 and will not update. Source: Department of Homeland Security

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Europe urgently needs to solve its Russian drone problem, Baltic officials say

VINSKI, Estonia (AP) — Estonia is extending a fence along its border with Russia and building anti-tank ditches and bunkers in preparation for a potential conflict with Moscow. But those defenses won’t guard against the threat it and its NATO allies face from Russian drones and .

Ben & Jerry's co-founder Greenfield leaves ice cream brand due clash with Unilever on social issues

Ben & Jerry's co-founder Jerry Greenfield is leaving the ice cream brand after 47 years, saying that the independence it once had to speak up on social issues has been stifled by parent company Unilever.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Supreme Court will weigh expanding Trump’s power to shape agencies by overturning 90-year-old ruling

WASHINGTON (AP) — said Monday it will consider expanding President Donald Trump's power to shape independent agencies by overturning a nearly century-old decision limiting when presidents can fire board members.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Northrop Grumman cargo ship reaches the International Space Station a day late after engine issue

CAPE CANAVERAL, Fla. (AP) — A supply ship arrived at the International Space Station on Thursday after a day’s delay due to a .

UNHCR official warns that the 1951 refugee convention is increasingly under threat

The U.N. refugee agency said Wednesday that governments around the world, especially in the Global North, and , are increasingly undermining the global convention on refugees and asylum-seekers — even threatening its very existence.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

Nucor And Reliance Seen As Steel's Strongest Defenders Against Market Challenges

NA steel sector struggles with pricing & demand, leaving investors cautious. HRC prices down 6%, but mills gaining market share & utilization up.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint

SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.

China's Tech Stocks Surge As AI Spending Accelerates

Chinese tech stocks rallied as bets on AI lift sentiment. Alibaba, Baidu, JD, PDD, NIO, Li Auto, and XPeng stocks all rose, showing renewed confidence in China's tech and EV sectors.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

British department store Harrods warns customers that some personal details taken in data breach

LONDON (AP) — Harrods, the luxury British department store, has warned some customers that their personal data may have been taken in a breach of its online systems.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Federal judge tosses Trump's $15B defamation lawsuit against New York Times

TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.

Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today

On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are the top stocks that gained the attention of retail traders and investors throughout the day.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Iraq's first industrial-scale solar plant opens in Karbala desert to tackle electricity crisis

KARBALA, Iraq (AP) — Iraq is set to open the country’s first industrial-scale solar plant Sunday in a vast expanse of desert in Karbala province, southwest of Baghdad.

Farm Aid celebrates 40 years of supporting family farmers with a concert in Minneapolis

MINNEAPOLIS (AP) — Farm Aid — the annual fundraising concerts launched by and during the farm crisis of the 1980s — celebrates its 40th anniversary on Saturday in Minneapolis.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

FDA proposes ban on Orange B, a food dye not used for decades

Federal regulators are proposing to remove another from the U.S. food supply — Orange B, a synthetic color that hasn't been used in the U.S. for decades.

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Trump's USDA Scraps Annual Hunger Survey Months After Cutting Food Stamps: Calls It 'Overly Politicized' And 'Rife With Inaccuracies'

The U.S. Department of Agriculture under President Donald Trump is ending the annual survey on hunger, known as the Household Food Security Report, calling it "overly politicized." This comes just months after the administration cut food stamp benefits for millions of low-income Americans.

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market

Pfizer Inc. (NYSE: PFE) stock climbed 1.87% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ: MTSR), a developer of anti-obesity drugs.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

US To Set $5 Billion Critical Minerals Fund

US to launch $5 billion fund for critical minerals, in partnership with Orion Resource Partners and other investors. Aimed at reducing reliance on Chinese supply chains and securing long-term resources.

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

Gainers Robo.ai (NASDAQ: AIIO) shares rose 30.0% to $2.64 during Thursday's regular session. The market value of their outstanding shares is at $685.3 million.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service